Biofourmis

Biofourmis is a global digital health and biotechnology company founded in 2015 and headquartered in Boston, Massachusetts, with additional offices in Singapore and India. The company specializes in AI-driven virtual care, remote patient monitoring, and digital therapeutics, focusing on delivering personalized care anywhere. Biofourmis utilizes predictive analytics and FDA-cleared AI algorithms to analyze over 120 biomarkers in real-time. This technology enables proactive interventions, improves patient outcomes, and reduces hospital readmissions. The company has developed a comprehensive suite of solutions, including its flagship Biovitals platform, which supports patient engagement, remote health tracking, and integration with electronic health records. Biofourmis also provides virtual care services, clinical trial support, and care delivery tools to enhance healthcare workflows. With a strong backing of $463.6 million in funding and a team of around 190 employees, Biofourmis has served over 1 million patients. The company partners with hospitals, health systems, payers, and biopharma companies to support clinical workflows and accelerate drug development.